Suppression of TGF-β signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane

Current Eye Research

Volumn 20, Issue 4, 2000, Pages 325-334

  Lee, Sao Bing ^a,b   Li, De Quan ^a   Tan, Donald T H ^b   Meller, Daniel ^a   Tseng, Scheffer C G ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amniotic membrane; Conjunctiva; Fibroblasts; Pterygium; TGF

Indexed keywords

ALPHA ACTIN; FIBROBLAST GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; INTEGRIN; PLASTIC; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AMNION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; PRIORITY JOURNAL; PTERYGIUM; SCAR FORMATION; TISSUE TRANSPLANTATION;

EID: 0033921080     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/0271-3683(200004)2041-5FT325     Document Type: Article

References (59)

1. Detels R, Dhir SP. Pterygium: A geographical study. Arch Ophthalmol. 1967;78:485-491.
2. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol. 1984;68: 343-346.
3. Hilgers JHCh. Pterygium: Its incidence, heredity and etiology. Am J Ophthalmol 1960;50:635-644.
4. Duke-Elder SS. Degenerative and pigmentary changes. In: Duke-Elder SS, ed. System of Ophthalmology. London: Henry Kimpton; 1977:569-585.
5. Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992;99:1056-1061.
6. Hill JC, Maske R. Pathogenesis of pterygium. Eye. 1989;3:218-226.
7. Mortada A, Hamdi IE, Shiwi TE, El-Einein GA. Histopathology of recurrent true pterygium. Bull Ophth Soc Egypt. 1968;61:117-122.
8. Cilova-Atanasova B. On the pathogenesis of pterygium. Folia Medica. 1971;13:67-72.
9. Cameron ME. Histology of pterygium: an electron microscopic study. Br J Ophthalmol. 1983;67:604-608.
10. Tan DTH, Chee S-P, Dear KBG, Lim ASM. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sciera excision. Arch Ophthalmol. 1997;115:1235-1240.
11. Wong WW. A hypothesis on the pathogenesis of pterygium. Ann Ophthalmol. 1978;303-308.
12. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol. 1984;98:225-228.
13. Kwok LS, Coroneo MT. A model for pterygium formation. Cornea. 1994;13:219-224.
14. Adamis AP, Starck T, Kenyon KR. The management of pterygium. Ophthalmol Clin North Am. 1990;3:611-623.
15. Prabhasawat P, Barton K, Burkett G, Tseng SCG. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology 1997;104:974-985.
16. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82:235-240.
17. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473-484.
18. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996;122:38-52.
19. Lee S-H, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
20. Shimazaki J, Yang H-Y, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology. 1997;104:2068-2076.
21. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431-441.
22. Kim JC, Lee D, Shyn KH. Clinical uses of human amniotic membrane for ocular surface diseases. In: Lass JH, ed. Advances in Corneal Research. New York: Plenum Press; 1997:117-134.
23. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol. 1997;115:1360-1367.
24. Tseng SCG, Prabhasawat P, Lee S-H. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124:765-774.
25. Fujishima H, Shimazaki J, Shinozaki N, Tsubota K. Trabeculectomy with the use of amniotic membrane for uncontrolled glaucoma. Ophthalmic Surg Lasers. 1998;29: 428-431.
26. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1-7.
27. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors. 1993;8:1-9.
28. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med. 1997; 214:27-40.
29. Massagué J, Attisano L, Wrana JL. The TGF- β family and its composite receptors. Trends Cell Biol. 1994;4: 172-178.
30. Derynck R, Feng X-H. TGF-β receptor signaling. Biochim Biophys Acta. 1997;1333:F105-F150.
31. Sporn MB, Roberts AB, Wakersfield IM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol. 1987;105:1039-1045.
32. Heino J, Ignotz RA, Hemler ME, Crouse C, Massagué J. Regulation of cell adhesion receptors by transforming growth factor- β. J Biol Chem. 1989;264:380-388.
33. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and tumor necrosis factor-α in the pterygium. Acta Histochem (Jena). 1996;98:195-201.
34. Tseng SCG, Li D-Q, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179:325-335.
35. Li D-Q, Tseng SCG. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163: 61-79.
36. Kamada S, Kakunaga T. The nucleotide sequence of a human smooth muscle alpha-actin (aortic type) cDMA. Nucleic Acids Res. 1989;17:1767-1769.
37. Moller-Pedersen T, Li HF, Petroll WM, Cavanagh HD, Jester JV. Confocal microscopic characterization of wound repair after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 1998;39:487-501.
38. Zhao Y. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts. Mol Cell Endocrinol 1999;150:91-97.
39. Shull MM, Doetschman T. Transforming growth factor-β1 in reproduction and development. Mol Reproduction Dev. 1994;39:239-246.
40. 3 during excisional wound repair. Am J Pathol. 1993;143:368-380.
41. Schmid P, Cox D, Bilbe G, McMaster G, Morrison C, Stähelin H, Lüscher N, Seiler W. TGF-βs and TGF-β type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol. 1993;171:191-197.
42. Pasquale LR, Dorman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-β1, TGF-β2, and TGF-β3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993;34:23-30.
43. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor β1 positively regulates its own expression in normal and transforming cells. J Biol Chem. 1988;263:7741-7746.
44. Li D-Q, Lee S-B, Tseng SCG. Differential expression and regulation of TGF-β1 TGF-2, TGF-3, TGF-βRI, TGF-βRII and TGF-βRIII in human corneal, limbal and conjunctival fibroblasts. Curr Eye Res. 1999;19:154-161.
45. Schmid P, Kunz S, Cerletti N, McMaster G, Cox D. Injury induced expression of TGF-β1 mRNA is enhanced by exogenously applied TGF-βs. Biochem Biophys Res Commun. 1993;194:399-406.
46. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
47. Bourguignon LYM. Interctions between the membrane-cytoskeleton and CD44 during lymphocyte signal transduction and cell adhesion. Curr Topics Membrane. 1998;43:293-312.
48. Faassen A, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB. Cell surface CD44-related chonddroitin sulfate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J Cell Sci. 1993;105:501-511.
49. Svee K, White J, Vaillant P, Jessurun J, Roongta U, Krumwiede M, Johnson D, Henke C. Acute lung injury firbroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest. 1996;98:1713-1727.
50. Knutson JR, Iida J, Fields GB, McCarthy JB. CD44/ chondroitin sulfate proteoglycan and α2β 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell. 1996;7:383-396.
51. Darby I, Skalli O, Gabbiani G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest. 1990;63:21-29.
52. Schmitt-Graff A, Desmouliére A. Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 1994:425:3-24.
53. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of α-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516.
54. Goldsmith KT, Gammon RB, Garver Jr RI. Modulation of bFGF in lung fibroblasts by TGF-β and PDGF. Am J Physiol. 1991;261:L378-L385.
55. Pertovaara L, Saksela O, Alitalo K. Enhanced bFGF gene expression in response to transforming growth factor-β stimulation of AKR-2B cells. Growth Factors. 1993;9:81-86.
56. Rosembaum J, Blazejewski S, Préaux A-M, Mallat A, Dhumeaux D, Mavier P. Fibroblast growth factor 2 and transforming growth factor β1 interactions in human liver myofibroblasts. Gastroenterology. 1995;109:1986-1996.
57. Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, Preaux A-M, Dhumeaux D, Rosenbaum J. Mitogenic effect of transforming growth factor-β1 on human Ito cells in culture: Evidence for mediation by endogeneous platelet-derived growth factor. Hepatology. 1993;18:137-145.
58. Kikuchi K, Yamkage A, Smith EA, LeRoy EC, Trojanowska M. Differential modulation of bFGF receptors by TGF-β in adult skin, scleroderma skin, and newborn foreskin fibroblasts. J Invest Dermatol. 1992;99:201-205.
59. Yamakage A, Kikuchi K, Smith EA, LeRoy EC, Trojanowska M. Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts. J Exp Med. 1992;175: 1227-1234.